2004•Acta PaediatricaRequires access

Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma?

Ildiko H. Koves, FC Jarman, F. J. Cameron

Open publisher page 7 citations

Abstract

AIM: To demonstrate that hyperprolactinaemia and/or prolactinoma occur in association with antipsychotic medication use. METHODS: Three case studies of patients with markedly elevated serum prolactin level (>132 microg/l); either antipsychotic medication induced or as a consequence of a prolactinoma. CONCLUSION: The management and investigation of children with markedly elevated serum prolactin levels remains poorly defined. In our case series, two patients were found to have prolactinomas. We suggest that paediatric patients with serum prolactin level above 50 microg/l in males and 70 microg/l in females, regardless of any antipsychotic medication use, receive magnetic resonance imaging to exclude prolactinoma.

About this research paper

What this paper is about

AIM: To demonstrate that hyperprolactinaemia and/or prolactinoma occur in association with antipsychotic medication use. METHODS: Three case studies of patients with markedly elevated serum prolactin level (>132 microg/l); either antipsychotic medication induced or as a consequence of a prolactinoma. CONCLUSION: The management and investigation of children with markedly elevated serum prolactin levels remains poorly defined. In our case series, two patients were found to have prolactinomas. We suggest that paediatric patients with serum prolactin level above 50 microg/l in males and 70 microg/l in females, regardless of any antipsychotic medication use, receive magnetic resonance imaging to exclude prolactinoma.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To demonstrate that hyperprolactinaemia and/or prolactinoma occur in association with antipsychotic medication use. METHODS: Three case studies of patients with markedly elevated serum prolactin level (>132 microg/l); either antipsychotic medication induced or as a consequence of a prolactinoma. CONCLUSION: The management and investigation of children with markedly elevated serum prolactin levels remains poorly defined. In our case series, two patients were found to have prolactinomas. We suggest that paediatric patients with serum prolactin level above 50 microg/l in males and 70 microg/l in females, regardless of any antipsychotic medication use, receive magnetic resonance imaging to exclude prolactinoma.

Key concepts: Hyperprolactinaemia, Prolactinoma, Medicine, Prolactin, Antipsychotic, Internal medicine, Endocrinology, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma? — Research Paper | ScholarLens